Simplex Trading
FSTX

Simplex Trading’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Simplex Trading’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,100
Closed -$32K – 10637
2022
Q4 		$32K Buy
5,100
+4,300
+538% +$23.8K ﹤0.01% 6406
2022
Q3 		$4K Sell
800
-13,800
-95% -$86.7K ﹤0.01% 9015
2022
Q2 		$91K Sell
14,600
-4,400
-23% -$14.8K ﹤0.01% 5700
2022
Q1 		$67K Buy
19,000
+7,200
+61% +$26.6K ﹤0.01% 6729
2021
Q4 		$59K Buy
11,800
+7,500
+174% +$45.2K ﹤0.01% 7047
2021
Q3 		$36K Hold
4,300
– – ﹤0.01% 7930
2021
Q2 		$36K Buy
+4,300
New +$36.7K ﹤0.01% 8058

Simplex Trading's FSTX Position: Q4 2022 in Review

Simplex Trading sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2022, closing a stake of 340 shares — an estimated $1.88K sold.

Simplex Trading first reported a position in FSTX in Q4 2021 and held it in 3 quarters. The position peaked at $54K in Q2 2022. 59 funds tracked by Wall St. Rank hold FSTX as of Q4 2022.

  • Simplex Trading reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 340 F-star Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.88K.
  • Simplex Trading first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Simplex Trading's F-star Therapeutics, Inc. Common Stock position peaked at $54K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.